Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ToMore Vision
Unknown (not specified on public sources)tomorevision.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
ToMore Vision has developed an AI-driven multi-modal data analysis platform for personalized cancer prognosis. The technology leverages genomics and other patient data to deliver precise, individualized predictions for cancer outcomes, aiming to improve treatment planning and patient care. The product is currently in early access with no published clinical trial results yet[1].
- Therapeutic areas
- Oncology
- Modalities
- Non-pharmacological therapyDevice (AI-powered software platform)
- Industry
- Digital Health Medical Devices
02
Partnerships
Not specified publicly
Beyond the preview
Go deeper on ToMore Vision.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ToMore Vision.